Celebrate the Bold, Colorful Characters of Brooklyn
THE BROOKLYN ROASTING COMPANY INTRODUCES TWO SUPER-PREMIUM COFFEE BLENDS TO THE KEURIG® K-CUP® POD SYSTEM
April 10, 2024 10:00 ET | The Brooklyn Roasting Company
Brooklyn, NY, April 10, 2024 (GLOBE NEWSWIRE) -- The Brooklyn Roasting Company, New York's best-loved local roasting company, today announced a new partnership with Keurig Dr Pepper (KDP) with the...
Nerdio logo large.jpg
Nerdio Unveils Major Upgrades in Nerdio Manager for Enterprise and Nerdio Manager for MSP, Enhancing Both Platforms
April 02, 2024 09:00 ET | Nerdio
CHICAGO, April 02, 2024 (GLOBE NEWSWIRE) -- Nerdio, a premier solution for organizations of all sizes looking to manage and cost-optimize native Microsoft cloud technologies, today announced...
Sandoz Logo Sandoz Blue RGB_adjusted.png
Sandoz receives FDA approval for first and only denosumab biosimilars
March 05, 2024 13:24 ET | Sandoz Group
MEDIA RELEASE Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®*...
Sandoz Logo Sandoz Blue RGB_adjusted.png
Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market
March 04, 2024 01:00 ET | Sandoz Group
MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab injection) for all approved indicationsDedicated retina sales and field reimbursement team...
Sandoz Logo Sandoz Blue RGB_adjusted.png
Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany
January 31, 2024 01:00 ET | Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE             Tyruko® approved for all indications of reference medicine             Tyruko® biosimilar to treat...
Sandoz Logo Sandoz Blue RGB_adjusted.png
Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market
January 22, 2024 01:00 ET | Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®**...
Heilind Electronics Features Stewart Connector's IP67 SealJack™ RJ45 Connectors
Heilind Electronics Features Stewart Connector's IP67 SealJack™ RJ45 Connectors
January 09, 2024 14:39 ET | Heilind Electronics
WILMINGTON, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of interconnect, electromechanical, and sensor products, announces the addition of Stewart...
Heilind Electronics Featuring Weidmüller OMNIMATE® 4.0 Fixed & Pluggable Terminal Blocks
Weidmüller OMNIMATE® 4.0 Fixed & Pluggable Terminal Blocks Featured at Heilind Electronics
January 04, 2024 10:30 ET | Heilind Electronics
WILMINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of electronic components and authorized distributor for Weidmüller, is featuring the OMNIMATE®...
3M™ Electrically Conductive Single-Sided Tape Featured at Heilind Electronics
New 3M™ Polyolefin Conductive Adhesive Series Featured at Heilind Electronics
December 28, 2023 12:28 ET | Heilind Electronics
WILMINGTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of interconnect, electromechanical, and sensor products, announces the addition of 3M™...
Weidmüller Klippon® Connect with SNAP IN Technology Terminal Blocks Featured at Heilind
Weidmüller Klippon® Connect with SNAP IN Technology Terminal Blocks Featured at Heilind Electronics
December 19, 2023 10:23 ET | Heilind Electronics
WILMINGTON, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of electronic components, is featuring the innovative Weidmüller Klippon® Connect terminal...